HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jane E Salmon Selected Research

Sphingosine-1-Phosphate Receptors

1/2022Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases.
11/2018Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jane E Salmon Research Topics

Disease

30Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 08/2002
27Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2021 - 01/2002
18Thrombosis (Thrombus)
10/2020 - 01/2002
16Inflammation (Inflammations)
01/2022 - 02/2002
12Pregnancy Complications
01/2022 - 12/2003
9Pre-Eclampsia (Preeclampsia)
01/2021 - 04/2008
9Rheumatoid Arthritis
11/2018 - 06/2003
7Spontaneous Abortion (Miscarriage)
01/2022 - 12/2003
5Autoimmune Diseases (Autoimmune Disease)
11/2018 - 03/2007
5Atherosclerosis
06/2010 - 12/2003
4Infections
01/2019 - 11/2002
4Hypertension (High Blood Pressure)
01/2016 - 02/2006
3Thrombophilia
10/2020 - 01/2004
3Vascular Diseases (Vascular Disease)
08/2017 - 06/2010
3Nephritis
06/2017 - 02/2003
3Thrombocytopenia (Thrombopenia)
08/2012 - 01/2002
3Proteinuria
09/2011 - 08/2007
2Rheumatic Diseases (Rheumatism)
01/2022 - 01/2020
2COVID-19
01/2021 - 09/2020
2Lupus Nephritis
06/2017 - 02/2003
2Hypertrophy
10/2014 - 01/2009
2Cardiovascular Diseases (Cardiovascular Disease)
10/2014 - 11/2005
2Arthritis (Polyarthritis)
02/2013 - 08/2007
2Carotid Artery Diseases
06/2010 - 07/2007
2Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2008 - 01/2007
2Atherosclerotic Plaque (Atheroma)
08/2007 - 02/2006
2Venous Thrombosis (Deep-Vein Thrombosis)
03/2007 - 12/2006
1Macular Degeneration (Age-Related Maculopathy)
01/2020
1Toxic Optic Neuropathy
01/2020
1Vascular System Injuries
11/2018
1Chronic Renal Insufficiency
01/2018
1Metabolic Bone Diseases (Osteopenia)
01/2018
1Hemarthrosis
01/2018
1Hemorrhage
01/2018
1Kidney Diseases (Kidney Disease)
06/2017
1Placental Insufficiency
03/2016

Drug/Important Bio-Agent (IBA)

24Antiphospholipid AntibodiesIBA
01/2022 - 12/2006
18Complement System Proteins (Complement)IBA
01/2018 - 12/2003
12AntibodiesIBA
11/2018 - 01/2002
11Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2006
7Antigen-Antibody Complex (Immune Complex)IBA
11/2018 - 06/2003
6Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 11/2004
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 01/2005
5CholesterolIBA
01/2009 - 12/2003
4Hydroxychloroquine (Plaquenil)FDA LinkGeneric
09/2020 - 10/2010
4Glycoproteins (Glycoprotein)IBA
10/2018 - 01/2011
4low density lipoprotein receptor-related protein 8IBA
10/2018 - 10/2014
4Immunoglobulin G (IgG)IBA
03/2018 - 02/2003
4CytokinesIBA
01/2018 - 07/2005
4Interleukin-10 (Interleukin 10)IBA
01/2011 - 06/2003
4HomocysteineIBA
06/2010 - 07/2007
4C-Reactive ProteinIBA
01/2009 - 02/2003
3Anticardiolipin AntibodiesIBA
11/2018 - 09/2011
3Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2018 - 07/2012
3Peptides (Polypeptides)IBA
03/2016 - 12/2003
3Monoclonal AntibodiesIBA
01/2016 - 02/2003
3Fc gamma receptor IIAIBA
10/2005 - 08/2002
2Sphingosine-1-Phosphate ReceptorsIBA
01/2022 - 11/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 02/2002
2Immunoglobulin M (IgM)IBA
03/2018 - 03/2007
2LigandsIBA
01/2018 - 02/2003
2HDL LipoproteinsIBA
08/2017 - 04/2015
2CreatinineIBA
06/2017 - 07/2007
2DNA (Deoxyribonucleic Acid)IBA
06/2017 - 09/2011
2Proteins (Proteins, Gene)FDA Link
06/2017 - 03/2011
2interleukin-21 (interleukin 21)IBA
01/2017 - 06/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2015 - 09/2006
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
08/2015 - 09/2006
2LipidsIBA
04/2015 - 10/2007
2Toll-Like Receptors (Toll-Like Receptor)IBA
07/2014 - 10/2010
2eculizumabFDA Link
06/2014 - 08/2012
2AnticoagulantsIBA
06/2014 - 11/2004
2Complement C5a (Complement 5a)IBA
02/2013 - 12/2003
2AutoantibodiesIBA
01/2011 - 04/2008
2Infliximab (Remicade)FDA Link
02/2008 - 10/2005
1Toll-Like Receptor 4IBA
01/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2022
1p38 Mitogen-Activated Protein KinasesIBA
01/2022
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2021
1Chloroquine (Aralen)FDA LinkGeneric
09/2020
1Estrogens (Estrogen)FDA Link
01/2020
1Retinaldehyde (Retinal)IBA
01/2020
1ElementsIBA
01/2019
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
10/2018
1InflammasomesIBA
01/2018
1DisintegrinsIBA
01/2018
1Epidermal Growth Factor (EGF)IBA
01/2018
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
01/2018
1Metalloproteases (Metalloproteinases)IBA
01/2018
1Antihypertensive Agents (Antihypertensives)IBA
06/2017
1InterleukinsIBA
01/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2017
1LDL Receptors (LDL Receptor)IBA
03/2016
1Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA
03/2016
1Tyrosine (L-Tyrosine)FDA Link
01/2016

Therapy/Procedure

13Therapeutics
01/2022 - 12/2003
2Ligation
08/2013 - 06/2003
1Prenatal Care (Care, Prenatal)
01/2021
1Punctures
01/2018
1Knee Replacement Arthroplasty (Total Knee Replacement)
10/2016